135 related articles for article (PubMed ID: 22413544)
1. [Melatonin agonist: a possible disease-modifying agent for Alzheimer's disease].
Matsubara E
Nihon Rinsho; 2012 Feb; 70(2):349-52. PubMed ID: 22413544
[TBL] [Abstract][Full Text] [Related]
2. Melatonin alleviates behavioral deficits associated with apoptosis and cholinergic system dysfunction in the APP 695 transgenic mouse model of Alzheimer's disease.
Feng Z; Chang Y; Cheng Y; Zhang BL; Qu ZW; Qin C; Zhang JT
J Pineal Res; 2004 Sep; 37(2):129-36. PubMed ID: 15298672
[TBL] [Abstract][Full Text] [Related]
3. Melatonin treatment restores mitochondrial function in Alzheimer's mice: a mitochondrial protective role of melatonin membrane receptor signaling.
Dragicevic N; Copes N; O'Neal-Moffitt G; Jin J; Buzzeo R; Mamcarz M; Tan J; Cao C; Olcese JM; Arendash GW; Bradshaw PC
J Pineal Res; 2011 Aug; 51(1):75-86. PubMed ID: 21355879
[TBL] [Abstract][Full Text] [Related]
4. Early melatonin supplementation alleviates oxidative stress in a transgenic mouse model of Alzheimer's disease.
Feng Z; Qin C; Chang Y; Zhang JT
Free Radic Biol Med; 2006 Jan; 40(1):101-9. PubMed ID: 16337883
[TBL] [Abstract][Full Text] [Related]
5. Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease.
Olcese JM; Cao C; Mori T; Mamcarz MB; Maxwell A; Runfeldt MJ; Wang L; Zhang C; Lin X; Zhang G; Arendash GW
J Pineal Res; 2009 Aug; 47(1):82-96. PubMed ID: 19538338
[TBL] [Abstract][Full Text] [Related]
6. The use of melatonin in Alzheimer's disease.
Cardinali DP; Brusco LI; Liberczuk C; Furio AM
Neuro Endocrinol Lett; 2002 Apr; 23 Suppl 1():20-3. PubMed ID: 12019347
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer's disease: roles for mitochondrial damage, the hydroxyl radical, and cerebrospinal fluid deficiency of melatonin.
Maurizi CP
Med Hypotheses; 2001 Aug; 57(2):156-60. PubMed ID: 11461164
[TBL] [Abstract][Full Text] [Related]
8. Possible therapeutic value of melatonin in mild cognitive impairment: a retrospective study.
Furio AM; Brusco LI; Cardinali DP
J Pineal Res; 2007 Nov; 43(4):404-9. PubMed ID: 17910609
[TBL] [Abstract][Full Text] [Related]
9. The human pineal gland and melatonin in aging and Alzheimer's disease.
Wu YH; Swaab DF
J Pineal Res; 2005 Apr; 38(3):145-52. PubMed ID: 15725334
[TBL] [Abstract][Full Text] [Related]
10. [Melatonin in the elderly and Alzheimer's disease].
Savaskan E
Praxis (Bern 1994); 2006 Nov; 95(47):1837-9. PubMed ID: 17168080
[No Abstract] [Full Text] [Related]
11. REM sleep behaviour disorder treated with melatonin in a patient with Alzheimer's disease.
Anderson KN; Jamieson S; Graham AJ; Shneerson JM
Clin Neurol Neurosurg; 2008 May; 110(5):492-5. PubMed ID: 18299172
[TBL] [Abstract][Full Text] [Related]
12. Ibuprofen modifies cognitive disease progression in an Alzheimer's mouse model.
Van Dam D; Coen K; De Deyn PP
J Psychopharmacol; 2010 Mar; 24(3):383-8. PubMed ID: 18957478
[TBL] [Abstract][Full Text] [Related]
13. Is modulation of nicotinic acetylcholine receptors by melatonin relevant for therapy with cholinergic drugs?
Markus RP; Silva CL; Franco DG; Barbosa EM; Ferreira ZS
Pharmacol Ther; 2010 Jun; 126(3):251-62. PubMed ID: 20398699
[TBL] [Abstract][Full Text] [Related]
14. A potential role for crystallization inhibitors in treatment of Alzheimer's disease.
Grases F; Costa-Bauzà A; Prieto RM
Med Hypotheses; 2010 Jan; 74(1):118-9. PubMed ID: 19666212
[TBL] [Abstract][Full Text] [Related]
15. Searching for new animal models of Alzheimer's disease.
Epis R; Gardoni F; Marcello E; Genazzani A; Canonico PL; Di Luca M
Eur J Pharmacol; 2010 Jan; 626(1):57-63. PubMed ID: 19836370
[TBL] [Abstract][Full Text] [Related]
16. Beneficial effects of melatonin in experimental models of Alzheimer disease.
Cheng Y; Feng Z; Zhang QZ; Zhang JT
Acta Pharmacol Sin; 2006 Feb; 27(2):129-39. PubMed ID: 16412260
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic efficacy of stemazole in a beta-amyloid injection rat model of Alzheimer's disease.
Han M; Liu Y; Tan Q; Zhang B; Wang W; Liu J; Zhang XJ; Wang YY; Zhang JM
Eur J Pharmacol; 2011 Apr; 657(1-3):104-10. PubMed ID: 21316359
[TBL] [Abstract][Full Text] [Related]
18. [The possible suppression of Alzheimer's disease by nonsteroidal anti-inflammatory drugs].
de Jong D; Jansen RW; Verbeek MM; Kremer HP
Ned Tijdschr Geneeskd; 2002 Nov; 146(44):2074-8. PubMed ID: 12448960
[TBL] [Abstract][Full Text] [Related]
19. [Pharmaceutical research strategies in Alzheimer's disease].
Wülfert E
J Pharm Belg; 1991; 46(1):67-77. PubMed ID: 2051302
[TBL] [Abstract][Full Text] [Related]
20. In vivo pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107: preclinical considerations in Alzheimer's disease.
Bitner RS; Bunnelle WH; Decker MW; Drescher KU; Kohlhaas KL; Markosyan S; Marsh KC; Nikkel AL; Browman K; Radek R; Anderson DJ; Buccafusco J; Gopalakrishnan M
J Pharmacol Exp Ther; 2010 Sep; 334(3):875-86. PubMed ID: 20504913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
